Barclays
BHC icon

Barclays’s Bausch Health BHC Stock Holding History

Barclays’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668K Buy
123,783
+103,818
+520% +$621K ﹤0.01% 3003
2025
Q4 		$139K Buy
19,965
+12,875
+182% +$84.7K ﹤0.01% 4479
2025
Q3 		$45.7K Sell
7,090
-54,318
-88% -$371K ﹤0.01% 4786
2025
Q2 		$409K Buy
61,408
+2,091
+4% +$10.7K ﹤0.01% 3876
2025
Q1 		$384K Sell
59,317
-34,206
-37% -$246K ﹤0.01% 3688
2024
Q4 		$754K Sell
93,523
-69,249
-43% -$571K ﹤0.01% 3566
2024
Q3 		$1.33M Sell
162,772
-59,019
-27% -$389K ﹤0.01% 3161
2024
Q2 		$1.55M Sell
221,791
-301,454
-58% -$2.28M ﹤0.01% 2319
2024
Q1 		$5.55M Sell
523,245
-315,541
-38% -$2.76M ﹤0.01% 1779
2023
Q4 		$6.73M Buy
838,786
+198,577
+31% +$1.45M ﹤0.01% 1848
2023
Q3 		$5.26M Sell
640,209
-314,017
-33% -$2.71M ﹤0.01% 1294
2023
Q2 		$7.63M Buy
954,226
+634,551
+198% +$4.68M ﹤0.01% 1108
2023
Q1 		$2.59M Buy
319,675
+924
+0.3% +$7.42K ﹤0.01% 2000
2022
Q4 		$2M Sell
318,751
-666,550
-68% -$4.66M ﹤0.01% 2266
2022
Q3 		$6.79M Buy
985,301
+935,470
+1,877% +$6.5M 0.01% 1010
2022
Q2 		$417K Buy
49,831
+46,360
+1,336% +$648K ﹤0.01% 3003
2022
Q1 		$79K Sell
3,471
-101,097
-97% -$2.47M ﹤0.01% 3897
2021
Q4 		$2.89M Sell
104,568
-20,255
-16% -$542K ﹤0.01% 2124
2021
Q3 		$3.48M Sell
124,823
-35,659
-22% -$1.01M ﹤0.01% 1879
2021
Q2 		$4.71M Buy
160,482
+11,797
+8% +$357K ﹤0.01% 1626
2021
Q1 		$4.72M Buy
148,685
+140,974
+1,828% +$4.13M ﹤0.01% 1566
2020
Q4 		$159K Sell
7,711
-2,280,873
-100% -$42.5M ﹤0.01% 3893
2020
Q3 		$35.6M Buy
2,288,584
+2,283,707
+46,826% +$39.3M 0.02% 501
2020
Q2 		$89K Sell
4,877
-251,714
-98% -$4.44M ﹤0.01% 4596
2020
Q1 		$3.98M Buy
256,591
+131,466
+105% +$3.17M ﹤0.01% 1665
2019
Q4 		$3.74M Sell
125,125
-120,406
-49% -$3.13M ﹤0.01% 2325
2019
Q3 		$5.36M Buy
245,531
+100,167
+69% +$2.29M ﹤0.01% 1793
2019
Q2 		$3.67M Sell
145,364
-269,108
-65% -$6.39M ﹤0.01% 2183
2019
Q1 		$10.2M Sell
414,472
-139,686
-25% -$3.34M 0.01% 1211
2018
Q4 		$10.2M Buy
554,158
+275,642
+99% +$6.56M 0.01% 1143
2018
Q3 		$7.15M Buy
278,516
+17,627
+7% +$404K 0.01% 1482
2018
Q2 		$6.06M Sell
260,889
-1,996,575
-88% -$41.3M 0.01% 1576
2018
Q1 		$35.9M Buy
2,257,464
+364,186
+19% +$6.78M 0.03% 556
2017
Q4 		$39.3M Buy
1,893,278
+55,563
+3% +$881K 0.03% 498
2017
Q3 		$26.3M Buy
1,837,715
+1,550,044
+539% +$23.4M 0.03% 550
2017
Q2 		$4.98M Sell
287,671
-520,226
-64% -$6.24M 0.01% 1479
2017
Q1 		$8.91M Sell
807,897
-3,314,816
-80% -$45.6M 0.01% 945
2016
Q4 		$59.9M Buy
4,122,713
+1,312,631
+47% +$24.1M 0.06% 235
2016
Q3 		$69M Sell
2,810,082
-3,416,691
-55% -$88.4M 0.08% 192
2016
Q2 		$125M Sell
6,226,773
-443,633
-7% -$12.6M 0.16% 96
2016
Q1 		$173M Buy
6,670,406
+1,396,462
+26% +$103M 0.26% 55
2015
Q4 		$533M Buy
5,273,944
+2,189,544
+71% +$246M 0.65% 13
2015
Q3 		$549M Sell
3,084,400
-784,237
-20% -$183M 0.66% 15
2015
Q2 		$859M Sell
3,868,637
-2,182,040
-36% -$484M 0.96% 6
2015
Q1 		$1.2B Sell
6,050,677
-2,624,770
-30% -$466M 1.38% 7
2014
Q4 		$1.24B Buy
8,675,447
+1,986,644
+30% +$267M 1.19% 6
2014
Q3 		$876M Sell
6,688,803
-461,457
-6% -$55M 0.84% 11
2014
Q2 		$901M Buy
7,150,260
+1,016,814
+17% +$130M 0.95% 12
2014
Q1 		$803M Buy
6,133,446
+1,549,434
+34% +$212M 0.91% 8
2013
Q4 		$536M Buy
4,584,012
+2,864,661
+167% +$314M 0.55% 17
2013
Q3 		$179M Buy
1,719,351
+190,520
+12% +$18.6M 0.21% 55
2013
Q2 		$132M Buy
+1,528,831
New +$120M 0.16% 82

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's BHC Position: Q1 2026 in Review

Barclays increased its Bausch Health (BHC) stake by 520% in Q1 2026, buying an estimated $621K and bringing the position to 123,783 shares worth $668K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Barclays first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.24B in Q4 2014. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Barclays held 123,783 shares of Bausch Health worth $668K as of Q1 2026.
  • Barclays bought 103,818 Bausch Health shares in Q1 2026, an estimated $621K.
  • Bausch Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3003 holding.
  • Barclays first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Bausch Health position peaked at $1.24B in Q4 2014.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.